Cialis to be approved from KFDA soon

Published: 2003-07-29 06:58:00

Updated: 2003-07-29 06:58:00

Lilly Korea's Cialis for the treatment of erectile dysfunction will be approved within this week from the Korea food and Drug Administration which completed its investigation on overall status of clinical trials conducted in local 10 hospitals.

The agency's earlier decision on the drug's appr...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK